1-[4-[3-(1,1-difluoroethyl)imidazo[1,2-a]pyrazin-6-yl]phenyl]cyclopropane-1-carbonitrile;ethane;6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine
C48H34F14N10O — CID 142362554
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[3-(1,1-difluoroethyl)imidazo[1,2-a]pyrazin-6-yl]phenyl]cyclopropane-1-carbonitrile;ethane;6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine
1-[4-[3-(1,1-difluoroethyl)imidazo[1,2-a]pyrazin-6-yl]phenyl]cyclopropane-1-carbonitrile;ethane;6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine (PubChem CID 142362554) has the molecular formula C48H34F14N10O and a molecular weight of 1032.84 g/mol. Its IUPAC name is 1-[4-[3-(1,1-difluoroethyl)imidazo[1,2-a]pyrazin-6-yl]phenyl]cyclopropane-1-carbonitrile;ethane;6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine.
Molecular Properties
| Compound Name | 1-[4-[3-(1,1-difluoroethyl)imidazo[1,2-a]pyrazin-6-yl]phenyl]cyclopropane-1-carbonitrile;ethane;6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine |
|---|---|
| PubChem CID | 142362554 |
| Molecular Formula | C48H34F14N10O |
| Molecular Weight | 1032.84 g/mol |
| Exact Mass | 1032.27 |
| IUPAC Name | 1-[4-[3-(1,1-difluoroethyl)imidazo[1,2-a]pyrazin-6-yl]phenyl]cyclopropane-1-carbonitrile;ethane;6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazine |
| SMILES | CC.CC(F)(F)c1cnc2cnc(-c3ccc(C4(C#N)CC4)cc3)cn12.FC(F)(F)Oc1ccc(-c2cn3c(C(F)(F)F)cnc3cn2)cc1.FC(F)(F)c1ccc(-c2cn3c(C(F)(F)F)cnc3cn2)cc1 |
| InChI | InChI=1S/C18H14F2N4.C14H7F6N3O.C14H7F6N3.C2H6/c1-17(19,20)15-8-23-16-9-22-14(10-24(15)16)12-2-4-13(5-3-12)18(11-21)6-7-18;15-13(16,17)11-5-22-12-6-21-10(7-23(11)12)8-1-3-9(4-2-8)24-14(18,19)20;15-13(16,17)9-3-1-8(2-4-9)10-7-23-11(14(18,19)20)5-22-12(23)6-21-10;1-2/h2-5,8-10H,6-7H2,1H3;1-7H;1-7H;1-2H3 |
| InChIKey | IDNZURLMKXOORJ-UHFFFAOYSA-N |
| XLogP | 13.84 |
| TPSA | 123.59 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 73 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1032.84 |
| LogP ≤ 5 | 13.84 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142362554 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.